19. Surgery and systemic therapy in older women with early stage triple negative breast cancer (TNBC) in England: A population based cohort study within the National Audit of Breast Cancer in Older Patients (NABCOP)

David Cromwell,David Dodwell,Jibby Medina,Yasmin Jauhari,Kieran Horgan,Melissa Gannon,Karen Clements

doi:10.1016/j.ejso.2019.01.205

19. Surgery and systemic therapy in older women with early stage triple negative breast cancer (TNBC) in England: A population based cohort study within the National Audit of Breast Cancer in Older Patients (NABCOP)

David Cromwell, David Dodwell + Show 5 more

https://doi.org/10.1016/j.ejso.2019.01.205

Copy DOI

Journal: European Journal of Surgical Oncology

Publication Date: Apr 5, 2019

Affiliation: London School of Hygiene & Tropical Medicine, University of Oxford, Royal College of Surgeons of England, Leeds Teaching Hospitals NHS Trust, Public Health England

#Triple Negative Breast Cancer #Early Stage Triple Negative Breast + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

Introduction: Chemotherapy is the only systemic therapy that can be used in TNBC and consequently there are no less toxic systemic treatments for older women with TNBC. The study evaluated the use of surgery and chemotherapy for early stage TNBC in women aged ≥70yrs compared to those aged 50–69yrs, as part of NABCOP.

Full Text